W
William Small
Researcher at Loyola University Chicago
Publications - 423
Citations - 15241
William Small is an academic researcher from Loyola University Chicago. The author has contributed to research in topics: Radiation therapy & Brachytherapy. The author has an hindex of 56, co-authored 396 publications receiving 12744 citations. Previous affiliations of William Small include University of Hong Kong & University of Chicago.
Papers
More filters
Journal ArticleDOI
Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.
Tamer Refaat,Eric D. Donnelly,Michelle S. Gentile,Caroline J. Novak,Ye Yuan,Gehan A Khedr,I. Helenowksi,John R. Lurain,Julian Schink,Alfred Rademaker,V. Sathiaseelan,Jonathan B. Strauss,William Small +12 more
TL;DR: Definitive chemoradiotherapy followed by conventional LDR BT boost is effective, feasible, and tolerable treatment modality for cervical cancer.
Journal ArticleDOI
Potential for use of amifostine in cervical cancer
TL;DR: The potential role of amifostine in combination with currently used cisplatin-based chemoradiotherapy regimens is being assessed in a Radiation Therapy Oncology Group phase I/II study in cervical cancer patients with positive para-aortic or high common iliac lymph nodes.
Journal ArticleDOI
Treatment of cervical cancer: overcoming challenges in access to brachytherapy
Katie Lichter,Chidinma P Anakwenze Akinfenwa,Emily MacDuffie,Rohini Bhatia,Christina Small,Jennifer Crocker,William Small,Junzo Chino,Daniel G. Petereit,Surbhi Grover +9 more
TL;DR: The review explores current brachytherapy utilization practices and efforts being undertaken to address barriers to implementation in low-, middle-, and high-income countries, and how these efforts are projected to impact future brachyTherapy access.
Journal ArticleDOI
Patterns of Care and Outcomes for Small Cell Carcinoma of the Cervix: A National Retrospective Analysis of 542 Cases
TL;DR: SCCC patients benefit from chemotherapy with aggressive local treatment, and patients who receive CRT that included brachytherapy did as well as patients who received chemotherapy followed by surgery.
Journal ArticleDOI
Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma and a solitary kidney: a case report.
Mehee Choi,John P. Hayes,Minesh P. Mehta,Andrew Swisher,William Small,Bharat B. Mittal,Gary R. MacVicar,John A. Kalapurakal,Samir V. Sejpal +8 more
TL;DR: A case of testicular seminoma with paraaortic adenopathy in a patient with a solitary kidney treated with radiotherapy, where IMRT reduced the volume of kidney receiving high dose but increased the volume receiving low dose.